Can a multiple sclerosis drug help patients walk better?
NCT ID NCT04387734
First seen Jan 08, 2026 · Last updated Apr 10, 2026 · Updated 18 times
Summary
This study is testing whether the drug Ocrevus can improve walking, balance, and leg strength in people with relapsing multiple sclerosis (MS) compared to other standard MS medications. Sixty participants will be assigned to receive either Ocrevus or another treatment for one year. Researchers will measure walking ability, take brain scans, and track any falls to see which treatment leads to better physical function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Georgia State University
Atlanta, Georgia, 30303, United States
-
Multiple Sclerosis Center of Atlanta
Atlanta, Georgia, 30327, United States
Conditions
Explore the condition pages connected to this study.